We have investigated whether cells derived from haemarthrosis caused by injury to the anterior cruciate ligament could differentiate into the osteoblast lineage in vitro. Haemarthroses associated with anterior cruciate ligament injuries were aspirated and cultured. After treatment with β β β β-glycerophosphate, ascorbic acid and dexamethasone or 1,25 (OH) 2 D 3 , a significant increase in the activity of alkaline phosphatase was observed. Matrix mineralisation was demonstrated after 28 days and mRNA levels in osteoblastrelated genes were enhanced.
We have investigated whether cells derived from haemarthrosis caused by injury to the anterior cruciate ligament could differentiate into the osteoblast lineage in vitro. Haemarthroses associated with anterior cruciate ligament injuries were aspirated and cultured. After treatment with β β β β-glycerophosphate, ascorbic acid and dexamethasone or 1,25 (OH) 2 D 3 , a significant increase in the activity of alkaline phosphatase was observed. Matrix mineralisation was demonstrated after 28 days and mRNA levels in osteoblastrelated genes were enhanced.
Our results suggest that the haemarthrosis induced by injury to the anterior cruciate ligament contains osteoprogenitor cells and is a potential alternative source for cell-based treatment in such injury.
The use of osteoprogenitor cells in the field of bone regeneration is promising. 1, 2 The most common source is bone marrow. Studies on mesenchymal stem cells derived from bone marrow stroma have demonstrated their ability to differentiate into mineralising osteoblasts. [3] [4] [5] However, aspiration of bone marrow is a painful, invasive procedure often requiring anaesthesia and may have associated morbidity. This has led to the investigation of alternative sources of osteoprogenitor cells which can be obtained with minimal invasion and discomfort. [6] [7] [8] [9] [10] There is increasing evidence to suggest that these cells are not exclusive to bone marrow, but are also present in various connective tissues such as trabecular bone, 6 synovium, 7 adipose tissue, 8, 9 and muscle. 10 However, these tissues are not ideal sources and usually require an invasive procedure under spinal or local anaesthesia. Recently, Jones et al 11 showed that synovial fluid from patients with arthritis contained a population of mesenchymal progenitor cells. Since aspiration of synovial fluid from a joint is a less invasive procedure and relieves the pain of capsular distension, it was thought that this may be an alternative source of cells for tissue engineering and cell-based therapy.
Rupture of the anterior cruciate ligament (ACL) is a common injury. Successful reconstruction requires rapid healing of tendon graft in a bony tunnel. However, integration of the graft to bone is sometimes unsatisfactory. 12 Recent studies have suggested that cell-based therapy may help. 13, 14 The incidence of haemarthrosis in patients with injury to the ACL is between 70% and 75%. 15, 16 Patients may be treated by aspiration of the haemarthrosis to relieve pain. We therefore hypothesised that cells derived from the haemarthrosis could be a source for cell-based therapy in such patients. We investigated whether fibroblastic cells isolated from a haemarthrosis caused by injury to the ACL were capable of osteogenic potential in vitro.
Patients and Methods
Our study was approved by the Ethics of Human Experiments Committee. Informed consent was obtained from all patients. The haemarthrosis was aspirated from the knees of eight patients with acute injury to the ACL within 48 hours of the injury. There were three men and five women with a mean age of 22 years (15 to 37).
The volume of fluid obtained ranged from 15 to 40 ml. There were no fatty deposits in the haemarthrosis indicating that no intra-articular fracture was present. Patients taking anticoagulants, steroids or non-steroidal antiinflammatory drugs in the three months before injury were excluded. All the patients were examined by MRI, which showed an isolated torn ACL and no evidence of osteochondral fractures or torn menisci. Arthroscopic reconstruction of the ACL using hamstring tendon was performed in all patients within six weeks of MRI and no chondral injuries or fractures were found. For comparison, peripheral blood from three healthy donors (aged 21, 25 and 39 years) was collected, isolated and expanded under identical conditions as described below. Cell isolation and expansion. The aspirated bloody joint fluid was transferred to sterile tubes and 15 ml of α-modified minimum essential medium (α-MEM; Sigma, St Louis, Missouri) containing heparin (10 U/ml; Mochida, Tokyo, Japan) were added to the tube and mixed well. The mixed fluid was layered on top of Ficoll-Paque PLUS (Amersham Biosciences, Uppsala, Sweden) in a 50 ml centrifuge tube, followed by centrifugation at 400 g for 25 minutes. Mononuclear cells present in the interface were harvested and washed with phosphate-buffered saline and the cell pellet was re-suspended in the original medium, α-MEM containing 10% heat-inactivated fetal bovine serum (Sigma), 2mM L -glutamine (Gibco BRL, Grand Island, New York) and antibiotics, and seeded in 75 cm 2 culture flasks. The cultures were incubated at 37˚C in an atmosphere of 5% CO 2 . The initial plating density was approximately 4 x 10 5 cells/cm 2 . The primary cells were allowed to attach without disturbance for four to five days after which the culture medium was changed twice weekly. Non-adherent cells were removed by changing the medium. The primary cells were cultured until they reached subconfluence at about 28 days. Only first-passage cells were used in all of the following procedures. Osteogenic differentiation. The in vitro osteogenesis assay was performed as described elsewhere. [3] [4] [5] Briefly, the subconfluent haemarthrosis-derived cells were harvested by digestion with 0.05% trypsin-0.02% EDTA and plated in six-well culture plates at a density of 1 x 10 4 cells/cm 2 in the original medium. The cells began to be incubated in osteogenic medium 48 hours after plating. The osteogenic medium consisted of the original medium plus 10 nM dexamethasone (Dex, Sigma), 10 mM β-glycerophosphate (Sigma) and 50 µg/ml of ascorbic acid (Wako, Osaka, Japan). Some cultures were treated with 10 nM (1,25(OH) 2 D 3 (VD) (Biomol Research Laboratories, Plymouth Meeting, Massachusetts) as a replacement of Dex for 48 hours before harvesting. The osteogenic stimulation was carried out for four weeks with the medium being changed twice per week. The control cells were maintained in the original medium.
Alizarin Red staining. The Monolayer cultures at day 28 were stained histochemically for matrix mineralisation using Alizarin Red staining as described previously. 17 Briefly, the cultures were rinsed twice with phosphatebuffered saline, fixed in 100% ethanol for 30 minutes and stained with 1% Alizarin Red S (Hartman Leddon Co, Philadelphia, Pennsylvania) in 0.28% ammonia water for ten minutes at room temperature. The stained cell layers were washed, rinsed twice with distilled water and air-dried. Alkaline phosphatase (ALP) activity assay. On days 7, 14, 21 and 28, alkaline phosphatase activities were assayed. The cell layer from each well was washed twice with phosphatebuffered saline, sonicated with a Microson Ultrasonic Cell Diaruptor XL2000 (Misonix, Farmingdale, New York) and stored at -20˚C until assayed for alkaline phosphatase activity. This was determined by measuring the release of p-nitrophenyl from p-nitrophenyl phosphate (Sigma) as substrate. The p-nitrophenol release was monitored by optical density at 410 nm. The optical densities obtained were then compared with a p-nitrophenol standard solution (Sigma). Protein concentration in the sonicate was measured using a DC Protein Assay kit (BIO-Rad, Heracules, California). The results are expressed as p-nitrophenol produced in nmol/min/mg of protein.
Reverse transcription polymerase chain reaction (RT-PCR).
On days 7, 14, 21, and 28, the total RNA was extracted using an RNeasy Kit (QIAGEN KK, Tokyo, Japan) according to the manufacturer's instructions. From each sample, approximately 1 µg of total RNA was reversetranscribed, using oligo (dT) primer, dNTP, 10 x PCR buffer, MgC1 2 , RNase inhibitor, and Mulv Reverse Transcriptase (all from Applied Biosystems, Branchberg, New Jersey). The converted cDNA samples were amplified by PCR using Taq Gold DNA polymerase (Applied Biosystems) and gene-specific primer sets listed in Table I . PCR reactions were carried out using a thermal cycler (Program Temperature Control System PC-707, ASTEC, Fukuoka, Japan). After denaturation at 94˚C for three minutes, the cycles were for one minute at 94˚C, one minute at the optimal annealing temperature and one minute at 72˚C, followed by a final incubation at 72˚C for ten minutes. To examine the mRNA expression of osteoblastic phenotypes, the following genes were examined: ALP, osteopon- tin, bone sialoprotein and osteocalcin. In all RT-PCR assays, the housekeeping gene glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was analysed to monitor RNA loading. The primer sequences, 18 annealing temperature and number of cycles for each PCR amplification are presented in Table I . The RT-PCR products were electrophoresed in 2% agarose gel containing ethidium bromide in tris-borate-EDTA electrophoresis buffer; visualised by ultraviolet transillumination.
Semiquantitative image analysis of the PCR products on the gel. Each gel was photographed on to positive/negative Polaroid film under ultraviolet illumination. The negative images were then captured using an image scanner. After the images had been recorded in a computer, the band intensities were processed with the NIH image program (Ver. 1.62; National Institutes of Health, Bethesda, Maryland) as described previously. 19 Quantification of cDNA was normalised to GAPDH values to control for variation in efficiency of cDNA synthesis. Statistical analysis. To assess differences between treated and control cells, Student's t-test was used. A value of p < 0.05 was considered to be statistically significant.
Results
Morphology of cultured/haemarthrosis-derived cells. In the primary culture, the adherent cells gave rise to colonies which first became visible around day seven of culture as cells having a fibroblast-like spindle shape. The colonies grew quickly, and merged to form a uniform multicellular layer by day 28. No adherent fibroblast-like cells or colonies were detected by day 28 in the cultures of the cells isolated from peripheral blood of the healthy donors (data not shown).
The first passaged cells in the osteogenic medium, supplemented with Dex, β-glycerophosphate, and ascorbic acid, changed morphologically from a fibroblast-like appearance to a more cuboidal shape (data not shown). By day 28, the treated cells appeared to be more densely packed and had a spindloid morphology compared with the control cells (data not shown).
Mineralisation. Under osteogenic conditions, nodules were first detected visually between days 10 and 14, and showed an increase in both size and number. On day 28, they were strongly stained dark red by Alizarin Red staining (revealing deposition of calcium), pointing to their mineralised nature. By contrast, no mineralised nodules were observed in the cells cultured under control conditions. Alkaline phosphatase activities. Under osteogenic conditions alkaline phosphatase activity increased with time, reaching maximum levels by day 21 (Fig. 1) . By contrast, under control conditions, it remained very low between days 7 and 28 in culture. The level of alkaline phosphatase activity under osteogenic conditions was significantly higher than that under control conditions after 7, 14, and 21 days in culture (p = 0.0248, 0.0006, 0.0004, respectively). Expression of osteoblast-related genes. As shown in Figure  2 , the mRNA expression of alkaline phosphatase, osteopontin and bone sialoprotein had a markedly higher level in the treated cells than in the controls. On alkaline phosphatase, significant differences between the treated cells and controls were observed at days 7, 14, and 21 (Fig. 2a) . On osteopontin and bone sialoprotein, significant differences were observed at days 21 and 28 (Figs 2b and 2c) . By contrast, expression levels of osteocalcin mRNA in both the treated and control cells remained low over a period of four weeks, and no significant differences were observed at all time points (data not shown). However, replacement of Dex with VD for the last 48 hours of induction resulted in a markedly higher expression of osteocalcin, and significant differences between the treated cells and control cells were observed at all time points (Fig. 2d) .
Discussion
Our study has demonstrated that cells derived from the haemarthrosis caused by injury to the ACL can be directed in vitro into the osteogenic lineage and mineralise the extracellular matrix when supplemented with Dex, ascorbic acid, and β-glycerophosphate. This indicates that the haemarthrosis harbours a potential source of osteoprogenitor cells similar to that of cells derived from bone marrow stro- Graph showing that the mean alkaline phosphatase (ALP) activity is significantly higher in treated than in control cells after 7, 14, and 21 days in culture (* p < 0.05;** p < 0.001, compared with the value of the control group). mal cells. [3] [4] [5] Cells derived from a haemarthrosis caused by injury to the ACL offer a unique advantage in contrast to other sources of osteoprogenitor cells. Haemarthrosis of the knee after trauma is accessible by aspiration and could be an ideal source of cells for tissue engineering and cellbased therapy.
To assess the in vitro osteogenic potential of haemarthrosis-derived cells, we used a similar approach to that previously described for human bone marrow stromal cells. 4, 5, 20 The primary culture of human haemarthrosis-derived cells showed the formation of colonies of fibroblast-like spindleshaped cells, similar to those of human bone marrow stromal cells, known as colony forming units-fibroblasts. 21 Induction of haemarthrosis-derived cells supplemented with Dex, β-glycerophosphate and ascorbic acid resulted in several events supporting osteogenesis. As in previous reports on cultures of bone marrow stromal cells, 3, 4 after treatment with osteogenic supplement, the morphological transformation of the cells from spindle-like into cuboidal (osteoblastic) shapes was observed. Alkaline phosphatase activity increased in a time-dependent manner under osteogenic conditions. Treatment with the osteogenic supplement for four weeks resulted in a greatly increased formation of mineralised nodules. Finally, RT-PCR analysis showed an increase in the expression level of osteogenic markers under osteogenic conditions, as shown by the enhancement of transcripts for ALP, osteopontin, bone sialoprotein and osteocalcin, which are traditionally associated with osteogenic commitment. 22, 23 Taken together, these results strongly suggest that these haemarthrosisderived cells can be induced towards the osteoblastic lineage.
Osteocalcin is a late bone marker only secreted by osteoblasts and also signals terminal osteoblast differentiation. 22, 23 In our study, treatment with Dex did not elevate the expression level of osteocalcin, but exposure to VD for 48 hours after removal of Dex resulted in up-regulation of osteocalcin expression. It has been found that human osteoblastic cells show a marked reduction in VD-dependent expression of osteocalcin when exposed to Dex. 3, 4, 24 This may be attributed to a reduction in the number of VD receptors on osteoblastic cells resulting from treatment with glucocorticoids. 25 Consistent with our results, the study on the osteoinduction of adipose-tissue-derived stromal cells demonstrated that exposure to Dex inhibited the expression of osteocalcin at all time points, but replacement of Dex with VD for 48 hours was sufficient to overcome this inhibitory effect. 9 What is the origin of the osteoprogenitor cells derived from ACL-injury-induced haemarthrosis? It is generally accepted that the haemarthrosis caused by an intra-articular osteochondral fracture contains fatty droplets derived from bone marrow. Therefore, in the case of osteochondral fracture-induced haemarthrosis, it is highly probable that these osteoprogenitor cells are derived from bone marrow. However, in haemarthrosis after isolated injury to the ACL there are no fatty droplets from bone marrow, since there has been no direct access for bone marrow into the joint. It is possible that these osteoprogenitor cells may be of local origin, and thus may be considered 'niche' progenitor cells. After injury to the ACL, uncommitted progenitor cells could be released into the joint from the infrapatellar fat pad 26 or synovium, 7 or could migrate directly from the bone marrow through specialised vascular channels to the joint space, as found in some animals. 27 Alternatively, they may be derived from circulating mesenchymal progenitor cells which enter the joint from the circulation. 28 Guided by a local repair response, reparative cell populations may be mobilised from more distant mesenchymal progenitor cell reservoirs and migrate to the site of injury. 29 Direct proof of these hypotheses requires further testing. It is possible that the haemarthrosis-derived cells used in our experiments may represent a heterogeneous population and are most likely at different stages of development. The observed differentiation may be, in part, due to the presence of bone cells in the haemarthrosis introduced by avulsion of ACL from bony attachment sites or micro-osteochondral injuries which could not be observed by arthroscopy. In future studies, expanded single-cell colonies will be required to determine the nature of individual adherent cells derived from haemarthrosis.
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